// App-Quantinova.ai

TP380 : Increasing the Sample Size in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial: What Did We Gain?

Researchers

Presenter

  • Jeff M Szychowksi

Principal Investigators

  • Oscar Benavente

  • Robert G Hart

  • Christopher S Coffey

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • University of Iowa, Iowa City, IA

  • McMaster University, Hamilton, ON, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved